Laird Christopher T, Burdorf Lars, French Beth M, Kubicki Natalia, Cheng Xiangfei, Braileanu Gheorghe, Sun Wenji, O'Neill Natalie A, Cimeno Arielle, Parsell Dawn, So Edward, Bähr Andrea, Klymiuk Nikolai, Phelps Carol J, Ayares David, Azimzadeh Agnes M, Pierson Richard N
Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Chair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Xenotransplantation. 2017 Mar;24(2). doi: 10.1111/xen.12294. Epub 2017 Mar 3.
Lung xenografts remain susceptible to loss of vascular barrier function within hours in spite of significant incremental advances based on genetic engineering to remove the Gal 1,3-αGal antigen (GalTKO) and express human membrane cofactor protein (hCD46). Natural killer cells rapidly disappear from the blood during perfusion of GalTKO.hCD46 porcine lungs with human blood and presumably are sequestered within the lung vasculature. Here we asked whether porcine expression of the human NK cell inhibitory ligand HLA-E and β2 microglobulin inhibits GalTKO.hCD46 pig cell injury or prolongs lung function in two preclinical perfusion models.
Lungs from pigs modified to express GalTKO.hCD46 (n=37) and GalTKO.hCD46.HLA-E (n=5) were harvested and perfused with human blood until failure or elective termination at 4 hours. Airway pressures and pulmonary artery hemodynamics were recorded in real time. Blood samples were also collected throughout the experiment for analysis. Porcine aortic endothelial cells (PAECs) from each genotype were cultured in monolayers in microfluidic channels and used in fluorescent cytotoxicity assays using human NK cells.
HLA-E expression on GalTKO.hCD46 PAECs was associated with significantly decreased antibody-dependent and antibody-independent NK-mediated cytotoxicity under in vitro conditions simulating physiologic shear stress. Relative to GalTKO.hCD46 pig lungs perfused with human blood on an ex vivo platform, additional expression of HLA-E increased median lung survival (>4 hours, vs 162 minutes, P=.012), and was associated with attenuated rise in pulmonary vascular resistance, and decreased platelet activation and histamine elaboration. As expected, HLA-E expression was not associated with a significant difference in NK cell adhesion to endothelial cells in vitro, or NK cell and neutrophil sequestration during organ perfusion.
We conclude human NK cell activation contributes significantly to GalTKO.hCD46 pig endothelial injury and lung inflammation and show that expression of HLA-E is associated with physiologically meaningful protection of GalTKO.hCD46 cells and organs exposed to human blood.
尽管基于基因工程在去除半乳糖-α1,3-半乳糖抗原(GalTKO)并表达人膜辅因子蛋白(hCD46)方面取得了显著进展,但肺异种移植在数小时内仍易出现血管屏障功能丧失。在用人类血液灌注GalTKO.hCD46猪肺的过程中,自然杀伤细胞会迅速从血液中消失,推测被隔离在肺血管系统中。在此,我们探讨在两种临床前灌注模型中,猪表达人类NK细胞抑制性配体HLA-E和β2微球蛋白是否能抑制GalTKO.hCD46猪细胞损伤或延长肺功能。
采集经基因改造表达GalTKO.hCD46的猪肺(n = 37)和GalTKO.hCD46.HLA-E的猪肺(n = 5),并用人类血液进行灌注,直至4小时后功能衰竭或选择性终止。实时记录气道压力和肺动脉血流动力学。在整个实验过程中还采集血样进行分析。将每种基因型的猪主动脉内皮细胞(PAECs)在微流控通道中单层培养,并用于使用人类NK细胞的荧光细胞毒性测定。
在模拟生理剪切应力的体外条件下,GalTKO.hCD46 PAECs上的HLA-E表达与抗体依赖性和非抗体依赖性NK介导的细胞毒性显著降低相关。相对于在体外平台上用人类血液灌注的GalTKO.hCD46猪肺,HLA-E的额外表达增加了肺中位存活时间(>4小时,vs 162分钟,P = 0.012),并与肺血管阻力的上升减弱、血小板活化和组胺释放减少相关。正如预期的那样,HLA-E表达在体外与NK细胞对内皮细胞的黏附或器官灌注期间NK细胞和中性粒细胞的隔离无显著差异。
我们得出结论,人类NK细胞活化对GalTKO.hCD46猪内皮损伤和肺部炎症有显著贡献,并表明HLA-E的表达与对暴露于人类血液的GalTKO.hCD46细胞和器官具有生理意义的保护作用相关。